While You Were Going to Overtime

Hockey fans, it doesn't get much better than yesterday's gold medal game. Canada took the gold, 3-2 in Overtime. To say it was exciting would be like saying the East Coast got a little bit of snow this winter.

Meanwhile, while you were going hostile (again) ...

• Merck KGAA is buying bioprocessing/bioproduction specialist Millipore in a $7.2 billion deal announced this morning.
  
• Astellas is making public its attempts to buy OSI Pharma for $3.5bb.


• The NYTimes reports on the scourge of drug resistant gram negative bacteria.


• President Obama says health care reform can't wait a generation.


• UK's NICE finally relents on PharmaMar's soft tissue sarcoma drug Yondelis, after Bayer commits to picking up some more of the tab.
  
• Vertex is going combo on HCV--telaprevir, meet 222. 222, meet telaprevir.
  
• AZ is buying out Merck's interest in its non-PPI products this year, the companies said. Price tag: $647 million.
• Will set backs for Actelion's IPF drug mean smooth sailing for Intermune next week?

image from flickr user Mary-Kay G used under creative commons